Vanguard Group Inc. increased its position in KindlyMD, Inc. (NASDAQ:NAKA – Free Report) by 32,737.0% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 6,036,750 shares of the company’s stock after buying an additional 6,018,366 shares during the quarter. Vanguard Group Inc. owned about 1.00% of KindlyMD worth $150,557,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Correct Capital Wealth Management purchased a new position in KindlyMD during the third quarter valued at $111,339,000. HighTower Advisors LLC bought a new position in shares of KindlyMD in the 3rd quarter worth approximately $12,970,000. Truist Financial Corp purchased a new stake in KindlyMD in the third quarter worth about $12,470,000. Rathbones Group PLC bought a new stake in shares of KindlyMD during the 2nd quarter valued at $1,523,000. Finally, Almanack Investment Partners LLC. purchased a new stake in KindlyMD during the 3rd quarter valued at approximately $1,377,000.
Analyst Ratings Changes
A number of analysts recently issued reports on the company. B. Riley Financial lowered their price target on KindlyMD from $1.00 to $0.50 and set a “buy” rating for the company in a research report on Monday, February 23rd. Weiss Ratings reiterated a “sell (e+)” rating on shares of KindlyMD in a report on Monday, December 29th. Two equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $4.25.
KindlyMD Price Performance
KindlyMD stock opened at $0.25 on Wednesday. The company has a market cap of $109.30 million, a PE ratio of -0.22 and a beta of 31.44. The stock’s 50 day moving average price is $0.35 and its 200 day moving average price is $1.46. KindlyMD, Inc. has a 1-year low of $0.23 and a 1-year high of $34.77.
About KindlyMD
Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.
Featured Articles
- Five stocks we like better than KindlyMD
- New Copper-Rich “Kraken” Zone Discovered
- Elon Warns “America Is Broke”. Trump’s Plan Inside.
- America’s 1776 happening again
- 3 Signs You May Want to Switch Financial Advisors
- Silver’s squeeze is tightening – opportunity forming
Want to see what other hedge funds are holding NAKA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for KindlyMD, Inc. (NASDAQ:NAKA – Free Report).
Receive News & Ratings for KindlyMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KindlyMD and related companies with MarketBeat.com's FREE daily email newsletter.
